In this longitudinal study serum levels of CXCL16, OPG and MMP-9 reflect MRI activity in RRMS, suggesting that these markers, in particular CXCL16 which also may predict disease activity, could be potential markers of disease activity in MS. Here, CXCL16 is linked to relapsing-remitting multiple sclerosis.